JP2014515744A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014515744A5 JP2014515744A5 JP2014503978A JP2014503978A JP2014515744A5 JP 2014515744 A5 JP2014515744 A5 JP 2014515744A5 JP 2014503978 A JP2014503978 A JP 2014503978A JP 2014503978 A JP2014503978 A JP 2014503978A JP 2014515744 A5 JP2014515744 A5 JP 2014515744A5
- Authority
- JP
- Japan
- Prior art keywords
- calcium channel
- microparticle
- therapeutic agent
- sterile
- type voltage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161471779P | 2011-04-05 | 2011-04-05 | |
| US61/471,779 | 2011-04-05 | ||
| PCT/US2012/032317 WO2012138854A1 (en) | 2011-04-05 | 2012-04-05 | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016205897A Division JP2017036320A (ja) | 2011-04-05 | 2016-10-20 | 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014515744A JP2014515744A (ja) | 2014-07-03 |
| JP2014515744A5 true JP2014515744A5 (cg-RX-API-DMAC7.html) | 2017-01-12 |
| JP6336899B2 JP6336899B2 (ja) | 2018-06-06 |
Family
ID=46969546
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014503978A Expired - Fee Related JP6336899B2 (ja) | 2011-04-05 | 2012-04-05 | 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム |
| JP2016205897A Withdrawn JP2017036320A (ja) | 2011-04-05 | 2016-10-20 | 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016205897A Withdrawn JP2017036320A (ja) | 2011-04-05 | 2016-10-20 | 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9364432B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2694133B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6336899B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20140052992A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103517726B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012240131B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2832501A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2513675A (cg-RX-API-DMAC7.html) |
| HK (1) | HK1198933A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL228539B (cg-RX-API-DMAC7.html) |
| RU (2) | RU2606169C2 (cg-RX-API-DMAC7.html) |
| SG (2) | SG10201602665UA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012138854A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10092524B2 (en) * | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| AU2012240131B2 (en) * | 2011-04-05 | 2017-07-20 | Edge Therapeutics | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
| US9399019B2 (en) * | 2012-05-09 | 2016-07-26 | Evonik Corporation | Polymorph compositions, methods of making, and uses thereof |
| EP3682912B1 (en) * | 2012-08-17 | 2025-11-26 | AMSilk GmbH | Use of self-assembling polypeptides as tissue adhesives |
| CN103211812A (zh) * | 2013-04-02 | 2013-07-24 | 苏州大学附属第一医院 | Skf96365在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用 |
| RU2741629C2 (ru) | 2016-09-20 | 2021-01-28 | Бракко Дайэгностикс Инк. | Системы и способы производства, инфузионного ввода и контроля доставки радиоактивного изотопа |
| US10646227B2 (en) | 2016-12-29 | 2020-05-12 | Cerepeutics, LLC | Systems and methods for acute treatment to limit intracerebral hemorrhage growth |
| WO2019018306A1 (en) * | 2017-07-17 | 2019-01-24 | Edge Therapeutics, Inc. | ADVANCED MICROPARTICULAR FORMULATIONS CONTAINING FORM 2 OF MICRONIZED POLYMORPHIC NIMODIPINE |
| US20190060109A1 (en) * | 2017-08-31 | 2019-02-28 | Gregory Todd Johnson | Method of Preventing Traumatic Brain Injury (TBI) |
| CN112074917B (zh) | 2018-03-28 | 2024-10-29 | 布拉科诊断公司 | 用γ检测器对放射性同位素递送系统进行校准的系统和技术 |
| CN112106148B (zh) | 2018-03-28 | 2024-10-29 | 布拉科诊断公司 | 放射性同位素发生器寿命的早期检测 |
| CN115104159A (zh) | 2020-02-21 | 2022-09-23 | 布拉科诊断公司 | 放射性同位素发生器早期突破检测 |
| US12016774B2 (en) | 2020-05-08 | 2024-06-25 | Medtronic Vascular, Inc. | Delivery system for prosthetic valve device having controlled release of inflow and outflow ends |
| RU2763254C1 (ru) * | 2020-08-31 | 2021-12-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ | Способ лечения церебрального вазоспазма при аневризматическом субарахноидальном кровоизлиянии |
| US11992642B2 (en) | 2020-10-30 | 2024-05-28 | Medtronic, Inc. | Implantable medical device for delivery of pharmacological agents to the deep brain structures |
| US11745003B2 (en) | 2020-10-30 | 2023-09-05 | Medtronic, Inc. | Implantable access port with one-directional filter |
| US11931545B2 (en) | 2020-10-30 | 2024-03-19 | Medtronic, Inc. | Drug infusion port |
| US12551613B2 (en) | 2020-10-30 | 2026-02-17 | Medtronic, Inc. | Implantable drug delivery port |
| US12226609B2 (en) | 2020-12-16 | 2025-02-18 | Medtronic, Inc. | Method to detect inadvertent delivery of drug to a subcutaneous pocket |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757128A (en) | 1986-08-01 | 1988-07-12 | Massachusetts Institute Of Technology | High molecular weight polyanhydride and preparation thereof |
| WO1990013361A1 (en) | 1989-05-04 | 1990-11-15 | Southern Research Institute | Improved encapsulation process and products therefrom |
| US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| IT1243390B (it) | 1990-11-22 | 1994-06-10 | Vectorpharma Int | Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione. |
| US5399665A (en) | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
| CA2180526A1 (en) | 1994-01-05 | 1995-07-13 | Joseph C. Hogan, Jr. | Method of identifying chemical compounds having selected properties for a particular application |
| US5712171A (en) | 1995-01-20 | 1998-01-27 | Arqule, Inc. | Method of generating a plurality of chemical compounds in a spatially arranged array |
| US5747058A (en) | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
| US5968542A (en) | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
| AT404429B (de) | 1995-06-09 | 1998-11-25 | Immuno Ag | Anti-plasma-antikörper-präparation |
| JP2909418B2 (ja) * | 1995-09-18 | 1999-06-23 | 株式会社資生堂 | 薬物の遅延放出型マイクロスフイア |
| PL189698B1 (pl) | 1996-03-12 | 2005-09-30 | Pg Txl Co | Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania |
| ATE318580T1 (de) * | 1996-12-20 | 2006-03-15 | Alza Corp | Gelzusammensetzungen und verfahren |
| CA2296056A1 (en) * | 1997-07-10 | 1999-01-21 | Keith Baker | Methods for universally distributing therapeutic agents to the brain |
| AU9596698A (en) * | 1997-10-15 | 1999-05-03 | Thomas Jefferson University | Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| JP2000070366A (ja) | 1998-09-02 | 2000-03-07 | Arute:Kk | 容器兼用注射器及び容器兼用注射器への凍結乾燥製剤の封入方法 |
| AU2607701A (en) | 1999-12-29 | 2001-07-09 | Regeneration Technologies, Inc. | System for reconstituting pastes and methods of using same |
| JP2003520830A (ja) | 2000-01-25 | 2003-07-08 | エドワーズ ライフサイエンシーズ コーポレイション | 再狭窄および吻合内膜過形成処置のための送達系 |
| WO2003020208A2 (en) * | 2001-08-31 | 2003-03-13 | Neuron Therapeutics, Inc. | Treatment of neurologic hemorrhage |
| US20040235801A1 (en) | 2001-10-25 | 2004-11-25 | Jean-Pierre Julien | Therapy for stroke |
| ATE470351T1 (de) | 2001-11-22 | 2010-06-15 | Japan Science & Tech Agency | Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht |
| AU2003219922B2 (en) | 2002-02-27 | 2009-09-10 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| TW200307011A (en) * | 2002-04-18 | 2003-12-01 | Chugai Pharmaceutical Co Ltd | Hyaluronic acid modifier |
| DE60334983D1 (de) | 2002-04-30 | 2010-12-30 | Bayer Healthcare Llc | Faktor vii oder faktor viia polypeptidvarianten |
| US20060094643A1 (en) | 2002-07-03 | 2006-05-04 | Yuri Svirkin | Compositions of hyaluronic acid and methods of use |
| US7713551B2 (en) | 2002-09-11 | 2010-05-11 | Elan Pharma International Ltd. | Gel stabilized nanoparticulate active agent compositions |
| JP4092994B2 (ja) | 2002-09-13 | 2008-05-28 | ニプロ株式会社 | プレフィルドシリンジキット |
| AU2003298749A1 (en) | 2002-11-26 | 2004-06-18 | Seacoast Neuroscience, Inc. | Buoyant polymer particles delivering therapeutic agents |
| WO2005003180A2 (en) | 2003-04-10 | 2005-01-13 | Pr Pharmaceuticals | A method for the production of emulsion-based micro particles |
| US20070207211A1 (en) | 2003-04-10 | 2007-09-06 | Pr Pharmaceuticals, Inc. | Emulsion-based microparticles and methods for the production thereof |
| AU2004259209A1 (en) | 2003-07-23 | 2005-02-03 | Pr Pharmaceuticals, Inc. | Controlled release compositions |
| US9149440B2 (en) * | 2003-09-02 | 2015-10-06 | University Of South Florida | Nanoparticles for drug-delivery |
| US20080124400A1 (en) * | 2004-06-24 | 2008-05-29 | Angiotech International Ag | Microparticles With High Loadings Of A Bioactive Agent |
| US20060205733A1 (en) | 2004-08-26 | 2006-09-14 | Encysive Pharmaceuticals | Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof |
| US8034762B2 (en) * | 2004-09-02 | 2011-10-11 | Cognosci, Inc. | Treatment of subarachnoid hemorrhage with Apo E analogs |
| WO2006084005A2 (en) | 2005-02-02 | 2006-08-10 | University Of Vermont And State Agricultural College | Emergence of a r-type ca2+channel(cav2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage |
| WO2006091459A2 (en) | 2005-02-24 | 2006-08-31 | Joslin Diabetes Center, Inc. | Compositions and methods for treating vascular permeability |
| US20060217340A1 (en) | 2005-03-23 | 2006-09-28 | University Of Vermont And State Agricultural College | Methods and products for treating hypertension by modulation of TRPC3 channel activity |
| KR20140014294A (ko) * | 2005-03-31 | 2014-02-05 | 리드스 에이비 | 유효 물질의 국소 전달을 기본으로 하는 전립선 질병의 치료 방법 |
| WO2006114105A2 (en) | 2005-04-26 | 2006-11-02 | Maxygen Holdings Ltd. | Use of modified factor vii for treating bleeding |
| EA012125B1 (ru) * | 2005-05-24 | 2009-08-28 | Утерон Фарма С.А. | Двухкамерное смесительное устройство для вязких фармацевтических веществ |
| US20070042049A1 (en) * | 2005-06-03 | 2007-02-22 | Elan Pharma International, Limited | Nanoparticulate benidipine compositions |
| US20090156481A1 (en) | 2005-07-15 | 2009-06-18 | Novo Nordisk Healthcare A/G | Use of Factor VIIa or Factor VIIa Equivalents for Preventing or Attenuating Haemorrhage Growth, and/or Oedema Generation Following Intracerebral Haemorrhage (ICH) in Patients Treated with Antiplatelet Therapy |
| US20070203079A1 (en) * | 2005-11-21 | 2007-08-30 | Caldwell Guy A | Methods of using small molecule compounds for neuroprotection |
| US9005183B2 (en) * | 2007-05-16 | 2015-04-14 | Health Knight, Llc | System and method for treating erectile dysfunction |
| US10092524B2 (en) | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| US8252302B2 (en) | 2007-06-11 | 2012-08-28 | Edge Therapeutics, Inc. | Methods and compositions to treat hemorrhagic conditions of the brain |
| NZ599430A (en) | 2007-06-11 | 2014-03-28 | Loch Macdonald R | A drug delivery system for the prevention of cerebral vasospasm |
| EP2222281B1 (en) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
| JP2009067771A (ja) * | 2008-05-27 | 2009-04-02 | Pacira Pharmaceuticals Inc | 神経学的疾患の治療方法 |
| US20100008968A1 (en) | 2008-06-26 | 2010-01-14 | Lampe John W | Method for treating cardiovascular diseases using rho kinase inhibitor compounds |
| EP2331082B1 (en) | 2008-09-11 | 2021-01-06 | Evonik Corporation | Solvent extraction microencapsulation with tunable extraction rates |
| CA2737484C (en) | 2008-09-18 | 2017-10-10 | Surmodics Pharmaceuticals, Inc. | Microencapsulation process with solvent and salt |
| JP2012515837A (ja) | 2009-01-23 | 2012-07-12 | サーモディクス ファーマシューティカルズ, インコーポレイテッド | 異なる非反復単位を有するポリマーを含むポリマー混合物、ならびにそれを作製および使用するための方法 |
| US20130059008A1 (en) | 2009-01-23 | 2013-03-07 | Jeffrey L. Atkinson | Drying methods for tuning microparticle properties |
| US20100189763A1 (en) | 2009-01-23 | 2010-07-29 | Heather Nettles | Controlled release systems from polymer blends |
| US20100291027A1 (en) | 2009-05-14 | 2010-11-18 | Jason Campbell | Hyaluronic acid (ha) injection vehicle |
| US20110033463A1 (en) * | 2009-08-06 | 2011-02-10 | Medtronic, Inc. | Apheresis, administration of agent, or combination thereof |
| JP5791629B2 (ja) | 2009-12-22 | 2015-10-07 | エボニック コーポレイションEvonik Corporation | 微粒子を調製する乳剤基調プロセス、及び、プロセスで利用されるワークヘッド構造体 |
| JP2013523752A (ja) | 2010-03-29 | 2013-06-17 | エボニック デグサ コーポレイション | 局所投与部位における医薬組成物の保持改善のための組成物および方法 |
| PL2658024T3 (pl) * | 2011-01-27 | 2022-12-05 | Lg Energy Solution, Ltd. | Taśma |
| AU2012240131B2 (en) * | 2011-04-05 | 2017-07-20 | Edge Therapeutics | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
-
2012
- 2012-04-05 AU AU2012240131A patent/AU2012240131B2/en not_active Ceased
- 2012-04-05 CN CN201280022344.1A patent/CN103517726B/zh not_active Expired - Fee Related
- 2012-04-05 HK HK14112548.6A patent/HK1198933A1/xx unknown
- 2012-04-05 RU RU2013148938A patent/RU2606169C2/ru not_active IP Right Cessation
- 2012-04-05 KR KR1020137029330A patent/KR20140052992A/ko not_active Ceased
- 2012-04-05 CA CA2832501A patent/CA2832501A1/en not_active Abandoned
- 2012-04-05 JP JP2014503978A patent/JP6336899B2/ja not_active Expired - Fee Related
- 2012-04-05 WO PCT/US2012/032317 patent/WO2012138854A1/en not_active Ceased
- 2012-04-05 SG SG10201602665UA patent/SG10201602665UA/en unknown
- 2012-04-05 EP EP12767399.4A patent/EP2694133B1/en not_active Not-in-force
- 2012-04-05 US US13/440,276 patent/US9364432B2/en not_active Expired - Fee Related
- 2012-04-05 GB GB1317446.1A patent/GB2513675A/en not_active Withdrawn
- 2012-04-05 SG SG2013072848A patent/SG193991A1/en unknown
-
2013
- 2013-09-29 IL IL228539A patent/IL228539B/en not_active IP Right Cessation
-
2016
- 2016-03-14 US US15/069,824 patent/US20160193198A1/en not_active Abandoned
- 2016-10-20 JP JP2016205897A patent/JP2017036320A/ja not_active Withdrawn
- 2016-11-16 RU RU2016144847A patent/RU2016144847A/ru not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013148938A (ru) | Система интравентрикулярной доставки лекарственного средства для улучшения исхода после повреждения головного мозга, нарушающего мозговое кровообращение | |
| JP5923493B2 (ja) | 注射可能なデポー組成物の調製方法 | |
| JP5882993B2 (ja) | 抗精神病薬デポ型注射用組成物 | |
| JP7038741B2 (ja) | 放出制御が容易な徐放性薬物微粒子の製造方法 | |
| AU2019200649B2 (en) | Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid | |
| JP2015522534A5 (cg-RX-API-DMAC7.html) | ||
| JP2016512527A5 (cg-RX-API-DMAC7.html) | ||
| RU2015143206A (ru) | Композиции и их применение для лечения осложнений аневризматического субарахноидального кровоизлияния | |
| US20200246470A1 (en) | Microparticles containing finasteride and preparation method thereof | |
| JP2014516080A5 (cg-RX-API-DMAC7.html) | ||
| JP6728221B2 (ja) | 長時間作用型注射可能パリペリドンエステルの抜かした投与量のための投与レジメン | |
| EP1994925A1 (en) | Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation | |
| WO2015141662A1 (ja) | 固体分散体 | |
| RU2014149362A (ru) | Полиморфные композиции, способы их получения и применение | |
| Etminan et al. | Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage | |
| KR20100017904A (ko) | 마이크로입자 중에 소마토스타틴 유도체를 포함하는 연장-방출 조성물 | |
| JP2022188127A (ja) | 注射可能な懸濁液 | |
| TW202302117A (zh) | 低吸附格列本脲調配物及方法 | |
| KR102363727B1 (ko) | 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법 | |
| KR20180115750A (ko) | 치료 입자를 동결건조시키기 위한 안정한 제제 | |
| JP2014509318A5 (cg-RX-API-DMAC7.html) | ||
| CA3233139A1 (en) | Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use | |
| TW201720447A (zh) | 裝載活性成份之奈米粒子、彼等之製法及用途 | |
| US8734852B2 (en) | Parenteral controlled release formulations of NSAID's | |
| AU2021201165A1 (en) | Controlled release compositions and their methods of use |